Arax Advisory Partners’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $465K | Sell |
6,552
-3,620
| -36% | -$271K | 0.01% | 679 |
|
|
2025
Q4 | $803K | Sell |
10,172
-11,830
| -54% | -$936K | 0.02% | 438 |
|
|
2025
Q3 | $1.81M | Buy |
22,002
+18,952
| +621% | +$1.49M | 0.03% | 494 |
|
|
2025
Q2 | $245K | Buy |
3,050
+218
| +8% | +$16.8K | 0.01% | 587 |
|
|
2025
Q1 | $227K | Buy |
2,832
+46
| +2% | +$3.83K | 0.01% | 495 |
|
|
2024
Q4 | $228K | Buy |
2,786
+2,749
| +7,430% | +$229K | 0.01% | 456 |
|
|
2024
Q3 | $3.05K | Buy |
37
+25
| +208% | +$1.87K | ﹤0.01% | 1912 |
|
|
2024
Q2 | $843 | Hold |
12
| – | – | ﹤0.01% | 2217 |
|
|
2024
Q1 | $890 | Hold |
12
| – | – | ﹤0.01% | 1168 |
|
|
2023
Q4 | $794 | Hold |
12
| – | – | ﹤0.01% | 1163 |
|
|
2023
Q3 | $755 | Sell |
12
-34
| -74% | -$2.12K | ﹤0.01% | 1185 |
|
|
2023
Q2 | $2.6K | Sell |
46
-126
| -73% | -$6.99K | ﹤0.01% | 963 |
|
|
2023
Q1 | $9.97K | Hold |
172
| – | – | ﹤0.01% | 689 |
|
|
2022
Q4 | $12.4K | Hold |
172
| – | – | ﹤0.01% | 620 |
|
|
2022
Q3 | $10K | Buy |
172
+157
| +1,047% | +$10K | ﹤0.01% | 662 |
|
|
2022
Q2 | $1K | Buy |
15
+3
| +25% | +$199 | ﹤0.01% | 1074 |
|
|
2022
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 1057 |
|
|
2021
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 1038 |
|
|
2021
Q3 | $1K | Buy |
+12
| New | +$722 | ﹤0.01% | 919 |
|
|
2020
Q2 | – | Sell |
-303
| Closed | -$9K | – | 696 |
|
|
2020
Q1 | $9K | Hold |
303
| – | – | ﹤0.01% | 529 |
|
|
2019
Q4 | $15K | Hold |
303
| – | – | ﹤0.01% | 436 |
|
|
2019
Q3 | $14K | Hold |
303
| – | – | ﹤0.01% | 440 |
|
|
2019
Q2 | $15K | Buy |
+303
| New | +$14.2K | 0.01% | 438 |
|
|
2018
Q4 | $12K | Hold |
303
| – | – | ﹤0.01% | 421 |
|
|
2018
Q3 | $14K | Sell |
303
-76
| -20% | -$3.47K | 0.01% | 443 |
|
|
2018
Q2 | $16K | Buy |
379
+339
| +848% | +$15.8K | 0.01% | 313 |
|
|
2018
Q1 | $1K | Sell |
40
-57
| -59% | -$2.77K | ﹤0.01% | 460 |
|
|
2017
Q4 | $4K | Sell |
97
-209
| -68% | -$11K | ﹤0.01% | 391 |
|
|
2017
Q3 | $15K | Buy |
306
+59
| +24% | +$2.87K | 0.01% | 297 |
|
|
2017
Q2 | $12K | Sell |
247
-606
| -71% | -$28.1K | 0.01% | 337 |
|
|
2017
Q1 | $40K | Buy |
853
+404
| +90% | +$19.3K | 0.02% | 226 |
|
|
2016
Q4 | $22K | Buy |
+449
| New | +$20.6K | 0.01% | 257 |
|
Other funds holding MET
VCM
VPM
Arax Advisory Partners's MET Position: Q1 2026 in Review
Arax Advisory Partners reduced its MetLife (MET) stake by 36% in Q1 2026, selling an estimated $271K and leaving 6,552 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #679.
Arax Advisory Partners first reported a position in MET in Q4 2016 and has held it in 32 quarters since. The position peaked at $1.81M in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Arax Advisory Partners held 6,552 shares of MetLife worth $465K as of Q1 2026.
- Arax Advisory Partners sold 3,620 MetLife shares in Q1 2026, an estimated $271K.
- MetLife made up 0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #679 holding.
- Arax Advisory Partners first reported a position in MetLife in Q4 2016 and has held it in 32 quarters since.
- Arax Advisory Partners's MetLife position peaked at $1.81M in Q3 2025.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.